Annexin A11 pathology was uncommon outside of FTLD–TDP Type C cases with a prevalence of 6% in LATE-NC, 6% in FLTD–TDP Type A, 3% in FTLD–TDP Type B, and 3% in ALS. Here, ANXA11 is linked to amyotrophic lateral sclerosis.